You searched for "MIGS"
One-year result of XEN45 implant for glaucoma: efficacy, safety, and postoperative management
The authors report a retrospective, non-randomised interventional case series of 39 patients who underwent a standalone XEN45 implantation. All 39 patients (female: male=1.2: 1) completed 12-month follow-up. Mean age was 70.1 years (range 32–92). Primary outcome measures were the intraocular...The National Student Ophthalmology Conference 2024
This will be our third annual conference, hosted virtually with the aim to inform and inspire current medical students with interests in ophthalmology. It is a collaborative effort of student representatives from medical schools across the country. - 8 guest...
MicroRNA inhibits corneal neovascularisation
MicroRNAs (miR) are small non-coding RNA that target mRNA for destruction. MiR target about 30% of the protein coding genes and fine tune their expression. MiR have been shown to be involved in several cellular processes including cell cycle, tissue...Sight Sciences at ESCRS
The Sight Sciences team recently returned from an incredibly busy and successful ESCRS congress in Copenhagen. The team were in town to support the MIGS masterclass programme and were pleased to spend time with customers, colleagues and contacts from across...Glaukos marks major milestone as global iStent sales reach 3 million
Glaukos is delighted to announce a major milestone revealing that 3 million iStents have been sold globally since the product first received approval from the FDA in 2012. Today iStent is the global market leader in the MIGs category with...UKEGS (UK and Éire Glaucoma Society) Conference 2024
Pretty soon it’s going to be the 9th of October, and a quick Wikipedia search will tell you of how this day in history has seen the founding of the Kingdom of Valencia, the initial whispers of the Prague Astronomical...Preview: UKEGS 2024
Pretty soon it’s going to be the 9th of October, and a quick Wikipedia search will tell you of how this day in history has seen the founding of the Kingdom of Valencia, the initial whispers of the Prague Astronomical...Sharing best practice and landmark evidence in glaucoma care
Evolving technology, best practice and landmark evidence in glaucoma care were reviewed by an international expert faculty in session presentations and debates during the 11th Moorfields International Glaucoma Symposium 2019. The authors were meeting chairs and provide an overview of...Cutting-edge practice in glaucoma care: what, how and why?
More effective treatments and drug delivery modalities, implantable minimally invasive glaucoma surgical (MIGS) devices, as well as accelerating clinical research programmes, will transform the surgical and clinical management of glaucoma in the near future. There is also an ever-greater emphasis...Newmedica strengthens glaucoma services with optometrist-turned-ophthalmologist appointment
Newmedica, a leading provider of ophthalmology services across England, has appointed Richard Stead as its lead for glaucoma. This strategic move underscores Newmedica's commitment to delivering exceptional and timely care for both NHS and private patients across the spectrum of...Sight Sciences marks 10,000 OMNI® procedures performed in the UK
Sight Sciences today marks a significant milestone for the OMNI® Surgical System in the United Kingdom, with more than 10,000 procedures performed across NHS and private hospitals since its UK launch in 2020. The milestone reflects the growing integration of...
